RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Gongwin Biopharm Holdings Co Stock

Gongwin Biopharm Holdings Co Liabilities 2024

Gongwin Biopharm Holdings Co Liabilities

199.85 M TWD

Ticker

6617.TWO

ISIN

KYG409471060

In 2024, Gongwin Biopharm Holdings Co's total liabilities amounted to 199.85 M TWD, a -13.15% difference from the 230.13 M TWD total liabilities in the previous year.

Gongwin Biopharm Holdings Co Aktienanalyse

What does Gongwin Biopharm Holdings Co do?

Gongwin Biopharm Holdings Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Gongwin Biopharm Holdings Co's Liabilities

Gongwin Biopharm Holdings Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Gongwin Biopharm Holdings Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Gongwin Biopharm Holdings Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Gongwin Biopharm Holdings Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Gongwin Biopharm Holdings Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Gongwin Biopharm Holdings Co stock

What is the level of liabilities of Gongwin Biopharm Holdings Co this year?

Gongwin Biopharm Holdings Co has a debt balance of 199.85 M TWD this year.

What were the liabilities of Gongwin Biopharm Holdings Co compared to the previous year?

The liabilities of Gongwin Biopharm Holdings Co have increased by -13.15% dropped compared to the previous year.

What are the consequences of high debt for investors of Gongwin Biopharm Holdings Co?

High liabilities can pose a risk for investors of Gongwin Biopharm Holdings Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Gongwin Biopharm Holdings Co?

Low liabilities mean that Gongwin Biopharm Holdings Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Gongwin Biopharm Holdings Co affect the company?

An increase in liabilities of Gongwin Biopharm Holdings Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Gongwin Biopharm Holdings Co affect the company?

A decrease in the liabilities of Gongwin Biopharm Holdings Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Gongwin Biopharm Holdings Co?

Some factors that can influence the liabilities of Gongwin Biopharm Holdings Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Gongwin Biopharm Holdings Co so important for investors?

The liabilities of Gongwin Biopharm Holdings Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Gongwin Biopharm Holdings Co take to modify the liabilities?

To change its liabilities, Gongwin Biopharm Holdings Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Gongwin Biopharm Holdings Co pay?

Over the past 12 months, Gongwin Biopharm Holdings Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gongwin Biopharm Holdings Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of Gongwin Biopharm Holdings Co?

The current dividend yield of Gongwin Biopharm Holdings Co is .

When does Gongwin Biopharm Holdings Co pay dividends?

Gongwin Biopharm Holdings Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gongwin Biopharm Holdings Co?

Gongwin Biopharm Holdings Co paid dividends every year for the past 0 years.

What is the dividend of Gongwin Biopharm Holdings Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Gongwin Biopharm Holdings Co located?

Gongwin Biopharm Holdings Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gongwin Biopharm Holdings Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gongwin Biopharm Holdings Co from 11/17/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did Gongwin Biopharm Holdings Co pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of Gongwin Biopharm Holdings Co in the year 2023?

In the year 2023, Gongwin Biopharm Holdings Co distributed 0 TWD as dividends.

In which currency does Gongwin Biopharm Holdings Co pay out the dividend?

The dividends of Gongwin Biopharm Holdings Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gongwin Biopharm Holdings Co

Our stock analysis for Gongwin Biopharm Holdings Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gongwin Biopharm Holdings Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.